ClinConnect ClinConnect Logo
Search / Trial NCT06592105

AI-enhanced Imaging Analysis to Predict Post-EVAR

Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NICE · Sep 9, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how advanced imaging technology, powered by Artificial Intelligence (AI), can help predict outcomes for patients with abdominal aortic aneurysms (AAA) after they undergo a procedure called endovascular aortic repair (EVAR). This procedure is important for treating AAA, which is a serious condition where the aorta, the main blood vessel in the body, becomes enlarged and can be life-threatening. By analyzing images taken before and after the surgery, the study aims to identify factors that could affect recovery and help improve how doctors monitor and treat complications after the procedure.

To participate in this trial, patients need to be adults over 18 years old who have had an elective EVAR for a non-ruptured AAA using a standard procedure. They also need to have specific imaging tests done before and after the surgery that show important details about their condition. If eligible, participants can expect to have their imaging data collected and analyzed to help create better prediction models for post-surgery outcomes. By participating, they are contributing to important research that could lead to improved care for future patients with similar conditions.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Pre-operative CTA should be performed maximum 6 months before the intervention,
  • At least one post-operative CTA should be performed between 1 month and 12 months following the intervention,
  • CTA needs to be contrast-enhanced with at least injection at arterial and/or portal time,
  • CTA should have a spacing no more than 1 mm.
  • Exclusion Criteria:
  • age \< 18 years, - patients with syndromic AAA,
  • patients who underwent open repair or complex EVAR (adjunctive sac embolization procedure, chimney/snorkel or fenestrated-branched endografts),
  • ruptured AAA,
  • previous history of AAA repair,
  • patients for whom one pre-operative and at least one post-operative CTA (within 1-year) are not available.

About Centre Hospitalier Universitaire De Nice

The Centre Hospitalier Universitaire (CHU) de Nice is a leading academic medical center located in Nice, France, dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, CHU de Nice is committed to enhancing patient care by conducting rigorous studies that explore new therapies and treatment modalities across various medical disciplines. With a focus on collaboration, the center integrates cutting-edge technology and interdisciplinary expertise to ensure the highest standards of research integrity and patient safety. CHU de Nice plays a vital role in the development of evidence-based medicine, contributing significantly to the global medical community.

Locations

Nice, Alpes Maritimes, France

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported